ATG-031

· Antengene Biologics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATG-031, covering 2025-06-09 to 2025-06-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas [Phase 1]